Display options
Share it on

J Clin Diagn Res. 2017 Jul;11(7):NC12-NC16. doi: 10.7860/JCDR/2017/24863.10253. Epub 2017 Jul 01.

Corneal Collagen Cross-linking for Treatment of Bacterial and Herpetic Keratitis.

Journal of clinical and diagnostic research : JCDR

Mohammad Reza Khalili, Hamid Reza Jahadi, Mashaallah Karimi, Masoud Yasemi

Affiliations

  1. Assistant Professor, Department of Ophthalmology, Poostchi Ophthalmology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
  2. Professor, Department of Ophthalmology, Poostchi Ophthalmology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
  3. Ophthalmologist, Department of Ophthalmology, Poostchi Ophthalmology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.

PMID: 28892949 PMCID: PMC5583818 DOI: 10.7860/JCDR/2017/24863.10253

Abstract

INTRODUCTION: Optimal management of infective keratitis is a formidable challenge and subject of ongoing studies. Recently, Collagen Cross-Linking (CXL) of the cornea has been considered to be a new effective therapeutic approach for resistant infectious keratitis.

AIM: Aim of the study was to evaluate the effectiveness of CXL with Ultraviolet-A (UV-A) and riboflavin for treatment of the refractory bacterial and Herpes Simplex Virus (HSV) keratitis.

MATERIALS AND METHODS: In this prospective interventional study, eight patients with diagnosis of infectious keratitis who were referred to Khalili Hospital eye emergency room, between 2014 and 2015 were included in the study. There were six patients with bacterial keratitis and two patients with HSV keratitis; they were resistant to conventional treatment and underwent CXL. Response to the treatment was considered as good if rapid epithelialization and rapid decrease in stromal infiltration occurred.

RESULTS: Microbial culture in the bacterial keratitis group showed coagulase negative

CONCLUSION: Although, CXL seems promising in the treatment of patients with refractory bacterial keratitis, but in some cases, it is ineffective. CXL may be an alternative treatment for refractory cases of HSV keratitis but recurrence is possible.

Keywords: Herpes simplex virus; Infectious keratitis; Keratoplasty

References

  1. JAMA Ophthalmol. 2014 Jun;132(6):737-41 - PubMed
  2. Br J Ophthalmol. 2014 Nov;98(11):1470-7 - PubMed
  3. Curr Eye Res. 2004 Jul;29(1):35-40 - PubMed
  4. J Refract Surg. 2009 Sep;25(9):S803-6 - PubMed
  5. Postgrad Med J. 2015 Oct;91(1080):565-71 - PubMed
  6. J Cataract Refract Surg. 2010 Feb;36(2):273-6 - PubMed
  7. Curr Opin Ophthalmol. 2010 Jul;21(4):293-300 - PubMed
  8. Cornea. 2008 Jun;27(5):590-4 - PubMed
  9. Klin Monbl Augenheilkd. 2000 Sep;217(3):190-3 - PubMed
  10. Ophthalmologe. 2010 Oct;107(10):951-2, 954-5 - PubMed
  11. Cornea. 2015 Apr;34(4):402-6 - PubMed
  12. Curr Opin Ophthalmol. 2016 Jul;27(4):348-52 - PubMed
  13. Cornea. 2016 Jan;35(1):62-71 - PubMed
  14. J Cataract Refract Surg. 2007 Nov;33(11):1982-4 - PubMed
  15. Am J Ophthalmol. 2007 May;143(5):755-762 - PubMed
  16. Ophthalmology. 2009 Apr;116(4):615-23 - PubMed
  17. Int J Hematol. 2002 Aug;76 Suppl 2:253-7 - PubMed
  18. Eur J Ophthalmol. 2009 Mar-Apr;19(2):295-7 - PubMed
  19. J Cataract Refract Surg. 2010 Mar;36(3):517-20 - PubMed
  20. Photochem Photobiol. 2004 Jul-Aug;80:15-21 - PubMed
  21. Br J Ophthalmol. 2010 May;94(5):660-1 - PubMed
  22. Vox Sang. 2000;78 Suppl 2:211-5 - PubMed
  23. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3402-8 - PubMed
  24. Int Ophthalmol Clin. 2007 Summer;47(3):1-6 - PubMed
  25. Ocul Surf. 2017 Apr;15(2):218-226 - PubMed
  26. Ophthalmologica. 2004 Mar-Apr;218(2):136-40 - PubMed
  27. Cornea. 2009 May;28(4):474-6 - PubMed
  28. J Ophthalmic Vis Res. 2015 Jan-Mar;10(1):16-20 - PubMed
  29. J Refract Surg. 2009 Sep;25(9):S799-802 - PubMed

Publication Types